NCT06337760
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- European Institute of Oncology Milan, Italy
Clinical trial condition
Neuroendocrine Neoplasm
Explore clinical trials studying Neuroendocrine Neoplasm. Study availability and eligibility vary by location and protocol.
24 public trials
11 recruiting studies
Neuroendocrine Neoplasm trial results
Not Yet Recruiting
Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms
NCT07684170
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +9 more
- Locations
-
Not specified
NCT02402920
- Conditions
- Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neoplasms, +6 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01638533
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT03980925
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +6 more
- Locations
-
- Institut Català d'Oncologia Badalona Badalona, Barcelona, Spain
- Institut Català d'Oncologia l'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
- Vall d'Hebron University Hospital Barcelona, Spain
- Hospital Universitario 12 de Octubre Madrid, Spain
NCT02399215
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
NCT05879055
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
- Fujian Province Cancer Hospital Fuzhou, Fujian, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Active, Not Recruiting
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT07118176
- Conditions
- Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +127 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
NCT03375320
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
- Locations
-
- Katmai Oncology Group Anchorage, Alaska, United States
- Kingman Regional Medical Center Kingman, Arizona, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors
NCT04750954
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
- University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States